Free Trial

UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by Hantz Financial Services Inc.

UnitedHealth Group logo with Medical background

Hantz Financial Services Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,855 shares of the healthcare conglomerate's stock after selling 10,403 shares during the quarter. UnitedHealth Group comprises approximately 0.7% of Hantz Financial Services Inc.'s holdings, making the stock its 29th biggest holding. Hantz Financial Services Inc.'s holdings in UnitedHealth Group were worth $38,878,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Robeco Institutional Asset Management B.V. lifted its stake in shares of UnitedHealth Group by 5.3% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 710,185 shares of the healthcare conglomerate's stock worth $359,254,000 after acquiring an additional 35,719 shares in the last quarter. Twelve Points Wealth Management LLC raised its position in shares of UnitedHealth Group by 32.6% in the 4th quarter. Twelve Points Wealth Management LLC now owns 1,655 shares of the healthcare conglomerate's stock valued at $837,000 after purchasing an additional 407 shares in the last quarter. Capital Investment Counsel LLC grew its position in shares of UnitedHealth Group by 2.3% during the fourth quarter. Capital Investment Counsel LLC now owns 14,478 shares of the healthcare conglomerate's stock worth $7,324,000 after buying an additional 327 shares in the last quarter. Mayflower Financial Advisors LLC raised its holdings in UnitedHealth Group by 3.8% in the fourth quarter. Mayflower Financial Advisors LLC now owns 4,433 shares of the healthcare conglomerate's stock valued at $2,242,000 after acquiring an additional 161 shares in the last quarter. Finally, Genesee Capital Advisors LLC grew its holdings in UnitedHealth Group by 10.2% during the 4th quarter. Genesee Capital Advisors LLC now owns 1,091 shares of the healthcare conglomerate's stock worth $552,000 after acquiring an additional 101 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $3.27 during mid-day trading on Friday, reaching $542.30. 4,120,450 shares of the company traded hands, compared to its average volume of 4,544,639. The firm has a market cap of $499.07 billion, a PE ratio of 34.99, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a fifty day simple moving average of $537.14 and a 200-day simple moving average of $564.96.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Morgan Stanley lowered their target price on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Finally, UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $629.32.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines